Definition & Need for Patenting MCQs With Answer

Introduction: This set of MCQs on Definition & Need for Patenting is designed for M.Pharm students preparing for MIP 104T – Intellectual Property Rights. The questions focus on core concepts: what a patent is, criteria for patentability, why pharmaceutical inventions are patented, procedural aspects (filing, priority, provisional applications), and policy issues such as public health safeguards and compulsory licensing. Each question encourages application-level understanding relevant to drug invention, formulations, processes and commercialization. Use these MCQs to test and deepen your grasp of patent rationale, scope of protection, and strategic considerations necessary for pharmaceutical research, development and regulatory compliance.

Q1. Which of the following best defines a patent?

• A time-limited exclusive right granted by a government to an inventor for a new, useful and non-obvious invention
• A perpetual right to prevent others from selling any similar product
• An automatic protection for any scientific discovery without formal application
• A contract between two companies to share technology

Correct Answer: A time-limited exclusive right granted by a government to an inventor for a new, useful and non-obvious invention

Q2. Which of these is NOT a standard criterion for patentability in most jurisdictions?

• Novelty
• Inventive step / non-obviousness
• Industrial applicability / utility
• Commercial profitability

Correct Answer: Commercial profitability

Q3. Why is patenting particularly important in the pharmaceutical industry?

• Because drug development is low-cost and patents are unnecessary
• Because patents provide exclusive marketing rights to recoup high R&D and clinical trial costs
• Because patents guarantee that a drug will be approved by regulators
• Because patents eliminate the need for good manufacturing practices

Correct Answer: Because patents provide exclusive marketing rights to recoup high R&D and clinical trial costs

Q4. What does “novelty” mean in patent law?

• The invention must be different from anything disclosed to the public anywhere before the filing date
• The invention must be more profitable than existing products
• The invention must have been described in at least one textbook prior to filing
• The invention must have been used in clinical practice for at least two years

Correct Answer: The invention must be different from anything disclosed to the public anywhere before the filing date

Q5. The Paris Convention gives applicants how much time to claim priority for a subsequent patent filing?

• 6 months
• 12 months
• 18 months
• 24 months

Correct Answer: 12 months

Q6. Which statement correctly describes the “inventive step” (non-obviousness)?

• An invention must be completely unpredictable with no logical link to prior art
• An invention must differ from prior art in a way that would not have been obvious to a person skilled in the art
• An invention must always use novel chemical entities only
• An invention is inventive if it is the first to be marketed regardless of prior publications

Correct Answer: An invention must differ from prior art in a way that would not have been obvious to a person skilled in the art

Q7. Which of the following is typically considered patentable subject matter in pharmaceuticals?

• New chemical entities, formulations, and manufacturing processes
• Pure scientific theories and mathematical methods
• General principles of medical practice such as surgical techniques (in many jurisdictions)
• Natural phenomena exactly as found in nature without modification

Correct Answer: New chemical entities, formulations, and manufacturing processes

Q8. What is the main practical effect of a granted patent for the patent holder?

• A right to manufacture and sell the invention anywhere in the world
• A right to exclude others from making, using, selling or importing the claimed invention in the granting country
• An international monopoly enforceable without further filings
• A mandatory license to any third party upon request

Correct Answer: A right to exclude others from making, using, selling or importing the claimed invention in the granting country

Q9. Which filing is typically used to secure an early filing date with minimal formal requirements in many jurisdictions?

• Complete specification with claims only
• Patent Cooperation Treaty (PCT) entry into national phase
• Provisional application
• Opposition filing

Correct Answer: Provisional application

Q10. What does the term “patent term” commonly refer to for most pharmaceutical patents?

• Lifetime of the inventor
• 20 years from the date of filing of the patent application (subject to maintenance fees and extensions)
• 5 years from grant with no extensions
• Indefinite as long as the product is sold

Correct Answer: 20 years from the date of filing of the patent application (subject to maintenance fees and extensions)

Q11. Which concept describes third-party clearance to commercialize a product without infringing existing patents?

• Patent prosecution
• Freedom-to-operate (FTO) analysis
• Patent opposition
• Patent term adjustment

Correct Answer: Freedom-to-operate (FTO) analysis

Q12. Under TRIPS, which mechanism allows a government to authorize the use of a patented invention without the patent owner’s consent for public health reasons?

• Patent assignment
• Compulsory licensing
• Patent pooling
• Patent abandonment

Correct Answer: Compulsory licensing

Q13. In assessing novelty, which of the following is considered prior art?

• Confidential laboratory notebook never disclosed publicly
• A peer-reviewed journal article published before the filing date
• An internal company memo that was never made available outside the company
• An invention disclosed only after the priority date

Correct Answer: A peer-reviewed journal article published before the filing date

Q14. For a pharmaceutical formulation, which claim type is often most strategically important to protect commercial products?

• Process claims only
• Composition-of-matter (formulation) and use claims together
• Claims to abstract scientific principles
• Claims to unpublished experimental data only

Correct Answer: Composition-of-matter (formulation) and use claims together

Q15. What is “enabling disclosure” (enablement) in a patent application?

• A description sufficient to allow a person skilled in the art to practise the invention without undue experimentation
• A detailed market analysis proving commercial viability
• A list of potential licensees for the invention
• A separate legal contract between inventor and patent office

Correct Answer: A description sufficient to allow a person skilled in the art to practise the invention without undue experimentation

Q16. Which of the following is a common reason for rejecting a patent application during examination?

• The invention claims a specific novel compound with adequate data
• Claims are anticipated by an earlier patent or publication (lack of novelty)
• The applicant paid the required fees on time
• The invention demonstrates surprising technical effect and inventive step

Correct Answer: Claims are anticipated by an earlier patent or publication (lack of novelty)

Q17. How does the “first-to-file” principle affect patent strategy?

• The earliest inventor always keeps rights, even without filing
• Filing promptly is crucial because rights are generally awarded to the first person to file an application
• It encourages public disclosure before filing to establish inventorship
• It makes provisional applications unnecessary

Correct Answer: Filing promptly is crucial because rights are generally awarded to the first person to file an application

Q18. What is a patent claim’s primary function?

• To provide background scientific theory of the invention
• To define the legal scope of protection conferred by the patent
• To list possible commercial partners
• To replace the specification entirely

Correct Answer: To define the legal scope of protection conferred by the patent

Q19. Which practice can help a pharmaceutical company extend commercial exclusivity beyond the original patent term?

• Filing a new patent for the same compound without any new inventive contribution
• Obtaining patent term extension or supplementary protection certificate for regulatory delay or filing follow-on patents for new formulations or indications
• Publicly disclosing manufacturing secrets to prevent competitors from patenting
• Voluntarily abandoning the original patent immediately after grant

Correct Answer: Obtaining patent term extension or supplementary protection certificate for regulatory delay or filing follow-on patents for new formulations or indications

Q20. Which statement reflects a limitation often applied to patenting of medical methods in some jurisdictions?

• Methods of medical treatment on the human or animal body may be excluded from patentability in certain jurisdictions
• All medical procedures are always patentable everywhere
• Patents automatically grant permission to practice the medical method clinically
• Medical methods are excluded only if they use chemical compounds

Correct Answer: Methods of medical treatment on the human or animal body may be excluded from patentability in certain jurisdictions

Download